Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
JUNS	JUPITER NEUROSCIENCES INC	$49.81M	-835.30%	-155.10%	-429.83%	975.20%	1.96	1.07	N/A	N/A	N/A
COCP	COCRYSTAL PHARMA INC	$11.18M	-144.10%	-102.80%	-193.21%	-406.50%	0.60	3.70	N/A	N/A	N/A
ATXS	ASTRIA THERAPEUTICS INC	$712.77M	-38.60%	-36.10%	-44.31%	-47.90%	0.08	14.89	N/A	N/A	N/A
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$95.28M	-51.10%	-45.70%	-64.16%	-278.10%	0.16	7.24	100.00%	-2,363.80%	-2,350.43%
BOLT	BOLT BIOTHERAPEUTICS INC	$11.06M	-94.40%	-54.80%	-80.26%	-55.60%	0.94	3.11	100.00%	-1,217.00%	-1,217.01%
DWTX	DOGWOOD THERAPEUTICS INC	$11.87M	-2,213.60%	-36.50%	-25.72%	-786.90%	2.06	7.80	N/A	N/A	N/A
CANF	CAN-FITE BIOPHARMA LTD	$5.00M	-264.10%	-129.00%	-157.13%	1,180.30%	0.85	3.60	100.00%	-1,571.30%	-1,571.25%
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$24.74M	-94.10%	-68.60%	-91.94%	-203.30%	0.39	4.60	61.80%	-541.30%	-562.49%
SYBX	SYNLOGIC INC	$19.77M	10.90%	7.50%	11.48%	-29.00%	0.37	3.68	N/A	N/A	N/A
NERV	MINERVA NEUROSCIENCES INC	$29.37M	-41.40%	31.40%	40.26%	19.40%	-1.95	6.15	N/A	N/A	N/A
CELU	CELULARITY INC	$52.05M	-6,372.60%	-57.70%	-128.73%	-65.20%	-5.72	0.25	55.10%	-165.40%	-147.39%
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-244.80%	-171.40%	-217.16%	-1,804.70%	0.30	3.63	100.00%	-3,171.60%	-3,445.89%
CNTX	CONTEXT THERAPEUTICS INC	$97.78M	-38.80%	-37.50%	-41.42%	-7,764.60%	0.06	19.09	N/A	N/A	N/A
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$7.12M	-72.80%	-66.20%	-62.17%	-285.40%	0.07	23.55	100.00%	-32,040.50%	-31,956.48%
CASI	CASI PHARMACEUTICALS INC	$22.33M	N/A	-99.10%	699.22%	-334.00%	-2.54	0.48	41.00%	-148.60%	-144.77%
PRTC	PURETECH HEALTH PLC	$427.05M	14.70%	8.90%	10.48%	15.50%	0.49	8.49	100.00%	793.00%	840.87%
PHAR	PHARMING GROUP NV	$891.20M	-3.60%	-2.00%	1.06%	1.30%	0.86	2.80	89.30%	-2.40%	1.12%
CALC	CALCIMEDICA INC	$41.36M	-206.50%	-103.80%	-128.84%	-172.70%	2.13	5.45	N/A	N/A	N/A
LPTX	LEAP THERAPEUTICS INC	$18.52M	-237.60%	-155.40%	-1,138.48%	485.50%	2.51	1.34	N/A	N/A	N/A
AZTR	AZITRA INC	$1.84M	-183.60%	-138.70%	-373.04%	-556.90%	0.78	1.24	N/A	N/A	N/A
PPBT	PURPLE BIOTECH LTD	$40.59M	8.20%	7.30%	9.59%	-194.60%	0.07	2.88	N/A	N/A	N/A
BLRX	BIOLINERX LTD	$16.45M	-49.70%	-17.50%	-3.67%	-12.90%	1.16	2.06	59.30%	-45.30%	-5.92%
PULM	PULMATRIX INC	$18.01M	-94.10%	-85.40%	-131.42%	1,844.30%	0.05	19.97	100.00%	-207,333.30%	-207,333.33%
PMN	PROMIS NEUROSCIENCES INC	$21.76M	-102.60%	-50.60%	2,678.82%	-23,768.00%	-25.86	0.97	N/A	N/A	N/A
ICCC	IMMUCELL CORP	$56.44M	6.20%	3.90%	4.19%	3.40%	0.56	3.85	37.40%	6.20%	6.27%
MTSR	METSERA INC	$6.62B	N/A	N/A	N/A	N/A	0.42	5.26	N/A	N/A	N/A
PCSA	PROCESSA PHARMACEUTICALS INC	$19.59M	-342.40%	-243.50%	-210.93%	-3,727.00%	0.34	3.45	N/A	N/A	N/A
ADVM	ADVERUM BIOTECHNOLOGIES INC	$90.23M	-332.80%	-113.50%	-283.66%	-121.10%	-5.76	1.54	100.00%	-18,387.40%	-18,387.40%
ARMP	ARMATA PHARMACEUTICALS INC	$177.89M	N/A	-29.20%	30.78%	-11.40%	-2.16	0.06	100.00%	-610.90%	-287.40%
LYRA	LYRA THERAPEUTICS INC	$9.47M	-412.00%	-61.20%	-93.74%	-75.60%	31.41	2.78	100.00%	-5,043.60%	-5,041.17%
APRE	APREA THERAPEUTICS INC	$8.16M	-78.90%	-62.70%	-105.05%	583.10%	0.29	5.34	100.00%	-1,646.80%	-1,766.47%
ONCO	ONCONETIX INC	$5.24M	-350.60%	-143.40%	-685.85%	819.20%	2.16	0.07	66.40%	-3,458.20%	-3,321.76%
MBIO	MUSTANG BIO INC	$6.35M	N/A	-107.30%	-284.92%	103.30%	3.13	1.34	N/A	N/A	N/A
MBRX	MOLECULIN BIOTECH INC	$14.08M	-1,676.40%	-128.10%	-194.08%	707.20%	-4.01	1.15	N/A	N/A	N/A
ANTX	AN2 THERAPEUTICS INC	$33.61M	-48.00%	-43.10%	-54.30%	-68.40%	0.10	9.67	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$109.54M	-63.80%	-58.00%	-51.85%	-319.40%	0.11	10.09	N/A	N/A	N/A
ALZN	ALZAMEND NEURO INC	$7.94M	-166.80%	-137.00%	-116.68%	4,925.40%	0.18	6.03	N/A	N/A	N/A
BRTX	BIORESTORATIVE THERAPIES INC	$12.29M	-145.30%	-93.90%	-221.32%	-192.50%	0.76	2.07	94.50%	-1,771.90%	-1,771.91%
OGEN	ORAGENICS INC	$880.48k	-954.70%	-311.80%	-7,344.29%	3,865.20%	27.10	1.04	N/A	N/A	N/A
KTTA	PASITHEA THERAPEUTICS CORP	$6.06M	-88.60%	-81.10%	-88.11%	4,718.40%	0.12	4.97	N/A	N/A	N/A
AKRO	AKERO THERAPEUTICS INC	$4.32B	-32.00%	-29.40%	-23.77%	-42.40%	0.07	16.80	N/A	N/A	N/A
PMCB	PHARMACYTE BIOTECH INC	$6.32M	-12.50%	-11.20%	-2.55%	-3.80%	0.04	18.01	N/A	N/A	N/A
CNSP	CNS PHARMACEUTICALS INC	$4.42M	-183.90%	-139.40%	-117.66%	1,437.20%	0.11	10.22	N/A	N/A	N/A
AIM	AIM IMMUNOTECH INC	$5.69M	N/A	-198.50%	248.39%	683.60%	-1.63	0.10	71.10%	-13,360.30%	-12,858.68%
MLEC	MOOLEC SCIENCE SA	$2.58M	-150.90%	-26.60%	-25.84%	-22.10%	10.22	1.48	-8.20%	-105.70%	-82.22%
ADTX	ADITXT INC	$32.84M	-425.20%	-117.40%	-249.64%	-181.80%	1.60	0.02	-4,371.10%	-306,599.30%	-250,836.49%
NXTC	NEXTCURE INC	$29.45M	-70.20%	-58.10%	-80.66%	-86.50%	0.20	10.26	N/A	N/A	N/A
MNOV	MEDICINOVA INC	$81.42M	-23.10%	-21.80%	-25.03%	-318.90%	0.06	13.26	13.60%	-8,775.80%	-8,771.68%
EVGN	EVOGENE LTD	$10.98M	N/A	-38.50%	-53.84%	-87.80%	-14.85	1.89	13.90%	-385.20%	-272.59%
ADAG	ADAGENE INC	$83.89M	-63.30%	-35.70%	-76.75%	184.60%	0.76	2.29	100.00%	-28,961.70%	-28,260.68%
ADIL	ADIAL PHARMACEUTICALS INC	$7.64M	-191.30%	-153.60%	-151.14%	-8,040.80%	0.22	5.02	N/A	N/A	N/A
GDTC	CYTOMED THERAPEUTICS LTD	$25.39M	-42.40%	-38.10%	-47.70%	-75.20%	0.16	5.81	84.10%	-1,629.20%	-1,619.98%
GLMD	GALMED PHARMACEUTICALS LTD	$7.27M	-48.30%	-43.00%	-45.36%	-78.30%	0.12	8.71	N/A	N/A	N/A
NTRB	NUTRIBAND INC	$80.99M	-410.60%	-353.10%	-119.11%	-3,780.30%	0.20	4.79	34.40%	-1,244.40%	-397.54%
MOLN	MOLECULAR PARTNERS AG	$135.88M	-51.00%	-44.90%	-55.21%	-116.80%	0.17	9.28	N/A	N/A	N/A
MRUS	MERUS NV	$7.19B	-53.30%	-44.90%	-49.01%	-90.10%	0.17	7.97	100.00%	-546.30%	-574.26%
NLSP	NLS PHARMACEUTICS LTD	$3.16M	N/A	-337.50%	N/A	363.90%	0.51	N/A	N/A	N/A	N/A
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$7.02M	-210.20%	-138.40%	-204.24%	-295.00%	0.49	4.07	N/A	N/A	N/A
MTVA	METAVIA INC	$24.03M	-212.00%	-107.20%	-191.84%	239.50%	0.92	2.08	N/A	N/A	N/A
MURA	MURAL ONCOLOGY PLC	$36.21M	-122.30%	-99.40%	-248.83%	-582.70%	0.49	2.87	N/A	N/A	N/A
NRXS	NEURAXIS INC	$26.82M	-652.30%	-194.90%	-149.54%	689.90%	0.67	2.82	84.80%	-242.60%	-220.34%
FBLG	FIBROBIOLOGICS INC	$20.22M	-1,219.20%	-146.50%	-914.69%	-666.90%	68.95	0.78	N/A	N/A	N/A
RNA	AVIDITY BIOSCIENCES INC	$8.42B	-27.00%	-24.60%	-26.87%	-34.70%	0.10	16.91	100.00%	-4,136.00%	-4,136.00%
ESLA	ESTRELLA IMMUNOPHARMA INC	$89.70M	N/A	-392.70%	198.13%	420.40%	-1.49	0.16	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$132.27M	-95.10%	-82.80%	-50.44%	7,950.30%	0.12	13.07	4.00%	-4,525.10%	-4,518.83%
ERNA	ERNEXA THERAPEUTICS INC	$14.42M	N/A	-682.30%	-780.58%	-703.90%	0.71	1.81	112.30%	-8,959.00%	-7,890.57%
ETNB	89BIO INC	$2.17B	-81.40%	-70.20%	-58.76%	-105.30%	0.13	18.03	N/A	N/A	N/A
RNTX	REIN THERAPEUTICS INC	$36.47M	-95.60%	-84.00%	-121.91%	1,321.10%	0.20	0.86	N/A	N/A	N/A
INAB	IN8BIO INC	$8.85M	-183.10%	-125.50%	-137.16%	-226.60%	0.27	7.03	N/A	N/A	N/A
IMAB	I-MAB	$405.04M	-18.80%	-17.70%	-19.16%	-32.20%	0.05	22.82	N/A	N/A	N/A
EDSA	EDESA BIOTECH INC	$13.06M	-103.10%	-78.70%	-37.56%	570.50%	0.06	15.73	N/A	N/A	N/A
VANI	VIVANI MEDICAL INC	$95.38M	-194.70%	-68.60%	-115.09%	-76.80%	4.89	1.30	N/A	N/A	N/A
EXOZ	EXOZYMES INC	$120.78M	-134.40%	-81.60%	-94.44%	-255.30%	0.34	6.19	N/A	N/A	N/A
KZIA	KAZIA THERAPEUTICS LTD	$5.20M	N/A	-134.30%	-2,049.17%	330.20%	-0.85	0.21	100.00%	-1,134.80%	-1,145.67%
NNVC	NANOVIRICIDES INC	$28.94M	-102.80%	-89.80%	-125.93%	-160.30%	0.17	1.28	N/A	N/A	N/A
VIVS	VIVOSIM LABS INC	$7.02M	-33.00%	-21.40%	-20.06%	-143.80%	0.26	4.52	97.90%	-1,399.30%	-1,389.44%
CYCN	CYCLERION THERAPEUTICS INC	$6.24M	-22.60%	-20.70%	-22.71%	-36.00%	0.09	5.03	100.00%	-89.50%	-89.51%
VRAX	VIRAX BIOLABS GROUP LTD	$2.44M	-109.60%	-101.80%	-108.73%	-324.80%	0.17	7.27	-838.20%	-95,739.20%	-98,816.73%
IMRN	IMMURON LTD	$11.11M	-50.30%	-40.70%	-63.80%	-160.50%	0.26	5.09	71.00%	-60.00%	-59.88%
CUE	CUE BIOPHARMA INC	$59.02M	-230.10%	-111.20%	-178.91%	-2,975.80%	1.24	1.60	100.00%	-469.30%	-463.15%
KPRX	KIORA PHARMACEUTICALS INC	$7.03M	-42.80%	-32.20%	-34.24%	-46.30%	0.44	5.14	100.00%	-60,257.30%	-49,209.99%
KZR	KEZAR LIFE SCIENCES INC	$45.48M	-63.50%	-52.10%	-73.19%	-72.50%	0.19	7.29	N/A	N/A	N/A
VTVT	VTV THERAPEUTICS INC	$69.48M	-206.40%	-55.90%	-92.45%	487.70%	8.71	4.98	100.00%	-115,029.40%	-115,029.41%
AEON	AEON BIOPHARMA INC	$989.72k	N/A	-20.10%	-64.59%	-21.60%	-1.74	1.12	N/A	N/A	N/A
PLUR	PLURI INC	$31.81M	N/A	-63.40%	-338.46%	-45.60%	-5.78	0.68	49.00%	-1,690.30%	-1,609.96%
GNFT	GENFIT SA	$193.01M	-51.70%	-18.80%	-13.83%	-17.70%	3.13	3.74	100.00%	-85.40%	-53.34%
GNTA	GENENTA SCIENCE SPA	$49.21M	-60.10%	-42.90%	-43.58%	-52.50%	0.78	13.20	N/A	N/A	N/A
PHGE	BIOMX INC	$13.11M	-121.90%	-68.90%	-93.25%	-102.30%	0.99	2.66	N/A	N/A	N/A
IBO	IMPACT BIOMEDICAL INC	$6.52M	-528.70%	-145.10%	907.95%	-2,020.30%	-2.56	0.06	-57.10%	-549,628.60%	-533,357.14%
VYNE	VYNE THERAPEUTICS INC	$9.07M	-77.60%	-63.10%	-99.12%	-137.10%	0.15	7.60	100.00%	-8,097.70%	-8,096.85%
TCRT	ALAUNOS THERAPEUTICS INC	$5.97M	-168.00%	-121.40%	-109.07%	-452.00%	0.29	3.48	100.00%	-99,825.00%	-99,825.00%
ATHE	ALTERITY THERAPEUTICS LTD	$76.85M	-43.20%	-37.20%	-28.43%	-222.50%	0.09	12.98	100.00%	-159.00%	-158.08%
SNSE	SENSEI BIOTHERAPEUTICS INC	$11.57M	-74.80%	-63.60%	-95.89%	-96.30%	0.16	7.64	N/A	N/A	N/A
SXTP	60 DEGREES PHARMACEUTICALS INC	$5.58M	-199.80%	-142.20%	-313.42%	-487.40%	0.76	2.27	37.70%	-976.00%	-918.16%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$199.22M	-123.50%	-118.40%	-138.38%	13,065.60%	0.12	8.72	N/A	N/A	N/A
SER	SERINA THERAPEUTICS INC	$51.25M	N/A	-168.80%	-233.25%	-2,039.70%	4.05	2.24	100.00%	-9,685.40%	-9,653.08%
LVTX	LAVA THERAPEUTICS NV	$42.75M	-106.60%	-38.40%	-49.09%	-82.60%	2.04	10.78	100.00%	-568.80%	-540.42%
TOVX	THERIVA BIOLOGICS INC	$2.98M	-169.30%	-82.40%	-126.11%	-177.60%	2.37	1.19	N/A	N/A	N/A
LPCN	LIPOCINE INC	$14.41M	-23.60%	-21.90%	-26.31%	-31.60%	0.09	12.71	100.00%	-107.10%	-107.10%
CMND	CLEARMIND MEDICINE INC	$4.28M	-173.80%	-70.50%	-364.89%	138.60%	2.73	1.32	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Mimedx Group (NASDAQ:MDXG)

Mimedx Group (NASDAQ:MDXG) is the #1 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Mimedx Group (NASDAQ:MDXG) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: B.

Mimedx Group (NASDAQ:MDXG) has a Due Diligence Score of 48, which is 25 points higher than the biotech industry average of 23.

MDXG passed 15 out of 33 due diligence checks and has strong fundamentals. Mimedx Group has seen its stock return 11.68% over the past year, overperforming other biotech stocks by 32 percentage points.

Mimedx Group has an average 1 year price target of $12.00, an upside of 56.86% from Mimedx Group's current stock price of $7.65.

Mimedx Group stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Mimedx Group, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the #2 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Incyte (NASDAQ:INCY) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.

Incyte (NASDAQ:INCY) has a Due Diligence Score of 60, which is 37 points higher than the biotech industry average of 23.

INCY passed 19 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock return 26.12% over the past year, overperforming other biotech stocks by 46 percentage points.

Incyte has an average 1 year price target of $88.75, a downside of -5.06% from Incyte's current stock price of $93.48.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Incyte, 50% have issued a Strong Buy rating, 0% have issued a Buy, 41.67% have issued a hold, while 8.33% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 36, which is 13 points higher than the biotech industry average of 23.

TBPH passed 11 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.91% over the past year, overperforming other biotech stocks by 98 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 75.08% from Theravance Biopharma's current stock price of $14.66.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.57%, which is 8 percentage points higher than the biotech industry average of 2.67%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.32%, which is the same as the biotech industry average of 2.67%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.51%, which is -2 percentage points lower than the biotech industry average of 2.67%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 68.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.7% in the last day, and up 2.96% over the last week. Cabaletta Bio was the among the top gainers in the biotechnology industry, gaining 46.15% yesterday.

Cabaletta Bio shares are trading higher after Cantor Fitzgerald maintained its overweight on the stock and raised Its price target from $15 to $30.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -11.08% in the past year. It has overperformed other stocks in the biotech industry by 9 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 78.95% in the past year. It has overperformed other stocks in the biotech industry by 99 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 57, which is 43 points higher than the biotech industry average of 14. It passed 4 out of 7 valuation due diligence checks.

Incyte's stock has gained 26.12% in the past year. It has overperformed other stocks in the biotech industry by 46 percentage points.

Are biotech stocks a good buy now?

58.9% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 59.57% over the next year.

2.89% of biotech stocks have a Zen Rating of A (Strong Buy), 4.96% of biotech stocks are rated B (Buy), 44.21% are rated C (Hold), 33.47% are rated D (Sell), and 14.46% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -9.18x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Mimedx Group (NASDAQ:MDXG)

2. Incyte (NASDAQ:INCY)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Mimedx Group (NASDAQ:MDXG)

2. Incyte (NASDAQ:INCY)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.